Literature DB >> 23076302

Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinoma.

Giuseppe Procopio, Elena Verzoni, Filippo de Braud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076302     DOI: 10.1159/000342768

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  1 in total

Review 1.  Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Authors:  Alessia Mennitto; Paolo Grassi; Raffaele Ratta; Elena Verzoni; Michele Prisciandaro; Giuseppe Procopio
Journal:  Ther Adv Urol       Date:  2016-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.